Search Results - "Cobham, M."
-
1
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
Published in Annals of oncology (01-06-2013)“…Bone marrow-derived endothelial progenitor cells (EPCs) are critical for metastatic progression. This study explores the effect of tetrathiomolybdate (TM), an…”
Get full text
Journal Article -
2
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary
Published in Annals of oncology (01-10-2010)“…Background: Ixabepilone is a semisynthetic epothilone B analogue that is active in taxane-resistant cell lines and has shown activity in patients with…”
Get full text
Journal Article -
3
Sexual transmission of human T-lymphotropic virus type I (HTLV-I)
Published in Annals of internal medicine (01-10-1989)“…To study the seroprevalence of human T-lymphotropic virus type I (HTLV-I) in a sexually active population and to determine sexual behavior risk factors for…”
Get more information
Journal Article -
4
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants
Published in American journal of epidemiology (01-06-1991)“…During 1985 and 1986, the authors measured antibodies to human T-lymphotropic virus type I (HTLV-I) in a cohort of 13,260 Jamaicans from all parts of the…”
Get more information
Journal Article -
5
Abstract P1-10-10: Tumor infiltrating lymphocytes (TILS) among high risk for recurrence breast cancer patients treated with tetrathimolybdate (TM)
Published in Cancer research (Chicago, Ill.) (15-02-2018)“…Background: Tumor infiltrating lymphocytes (TILs) evaluated in the primary tumor biopsy or surgical resection have been well established as having prognostic…”
Get full text
Journal Article -
6
Abstract PD9-07: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with high risk breast cancer (BC): Role of collagen processing and tumor microenvironment
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Background: Copper is an important catalytic cofactor in several biological functions and is essential for lysyl oxidase (LOX), a key enzyme in cross-linking…”
Get full text
Journal Article -
7
Abstract P1-10-02: A phase II study of copper-depletion using tetrathiomolybdate in patients with breast cancer at high risk for recurrence: Updated results
Published in Cancer research (Chicago, Ill.) (15-02-2018)“…Background: Metals have emerged as a viable therapeutic target for a new generation of anti-cancer and anti-metastatic agents. Copper, an essential trace…”
Get full text
Journal Article -
8
Abstract P3-02-02: Targeting the tumor microenvironment: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence
Published in Cancer research (Chicago, Ill.) (15-02-2016)“…Background: Bone marrow derived VEGFR2+ endothelial progenitor cells (EPCs) and copper-dependent pathways, including lysyl oxidase (LOX), are critical…”
Get full text
Journal Article -
9
Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. II. Geographic and ecologic determinants
Published in American journal of epidemiology (01-06-1991)“…An island-wide cohort of 13,260 Jamaicans who applied for food-handling licenses during 1985 and 1986 were tested for antibodies to human T-cell lymphotropic…”
Get more information
Journal Article -
10
Abstract P2-16-14: The Effect of Tetrathiomolybdate (TM) on Circulating Endothelial Progenitor Cells in Women at Moderate to High Risk of BC Recurrence
Published in Cancer research (Chicago, Ill.) (15-12-2010)“…Background: Bone marrow (BM) derived endothelial progenitor cells (EPCs) are critical to tumor angiogenesis, are increased in BC patients (pts) and are…”
Get full text
Journal Article -
11
A Phase II Trial Tetrathiomolybdate (TM), a Copper Depleting Compound, and Its Effect on Circulating Endothelial Progenitor Cells (EPCs) in Patients with Breast Cancer (BC) at High Risk of Recurrence
Published in Cancer research (Chicago, Ill.) (15-12-2009)“…Background: EPCs are critical to tumor angiogenesis, are increased in BC patients (pts) and are probably an early marker for paclitaxel response. Copper is…”
Get full text
Journal Article -
12
The effect of tetrathiomolybdate on endothelial progenitor cells in patients at high risk for breast cancer recurrence
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
13
Phase I trial of a histone deacetylase inhibitor (HDACI) and retinoid acid (RA) in patients (pts) with advanced solid tumor malignancies
Published in Journal of clinical oncology (20-06-2006)“…Abstract only 13114 Background: Transcription of RA responsive genes is inhibited by co-repressor complexes which have HDAC activity. Pre-clinical data…”
Get full text
Journal Article -
14
Future leadership in public health in the Commonwealth Caribbean, including the role of the University of the West Indies
Published in West Indian medical journal (01-12-1985)Get more information
Journal Article -
15
Phase I/II trial of interferon α2b and ATRA-IV in the treatment of patients with advanced renal cancer
Published in Journal of clinical oncology (01-06-2005)“…Abstract only…”
Get full text
Journal Article -
16
Phase 1/2 Clinical Trial of Interferon [alpha]2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma
Published in Journal of immunotherapy (1997) (01-09-2007)“…To evaluate the feasibility, efficacy, and biologic effects of weekly liposome-encapsulated all-trans retinoic acid (ATRA-IV) plus interferon [alpha]2b (IFN)…”
Get full text
Journal Article -
17
Abstract P6-05-06: Association of HER2/neu single nucleotide polymorphism with trastuzumab-related cardiotoxicity
Published in Cancer research (Chicago, Ill.) (15-12-2013)“…Background: Treatment with trastuzumab prolongs overall survival when given to patients (pts) with Her2/neu+ breast cancer (BC). The primary toxicity of…”
Get full text
Journal Article -
18
Abstract P6-11-04: Targeting the tumor microenvironment: tetrathiomolybdate decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
Published in Cancer research (Chicago, Ill.) (15-12-2012)“…Background: Bone marrow-derived endothelial progenitor cells (EPCs) constitute an important part of the tumor microenvironment and are critical for metastatic…”
Get full text
Journal Article -
19
Abstract P1-15-07: Ixabepilone-associated peripheral neuropathy in metastatic breast cancer patients and its effects on the ultrastructure of neurons
Published in Cancer research (Chicago, Ill.) (15-12-2012)“…Background: Peripheral neuropathy is a dose-limiting toxicity of most microtubule-stabilizing chemotherapeutic agents. Ixabepilone, a semisynthetic analog of…”
Get full text
Journal Article -
20
The effect of tetrathiomolybdate on circulating endothelial progenitor cells in patients with breast cancer at high risk of recurrence
Published in Cancer research (Chicago, Ill.) (15-01-2009)“…Abstract #1036 Background: Endothelial progenitor cells are critical to tumor angiogenesis and are increased in breast cancer patients. Copper is required for…”
Get full text
Journal Article